First Eagle Investment Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-729,636
Closed -$6.88M 405
2025
Q2
$6.88M Sell
729,636
-112,000
-13% -$988K 0.01% 211
2025
Q1
$9.12M Sell
841,636
-15,500
-2% -$156K 0.02% 163
2024
Q4
$8.16M Sell
857,136
-73,302
-8% -$742K 0.02% 205
2024
Q3
$10.4M Buy
930,438
+32,686
+4% +$347K 0.02% 171
2024
Q2
$8.98M Buy
897,752
+302,801
+51% +$3.08M 0.02% 183
2024
Q1
$6.85M Buy
594,951
+91,772
+18% +$780K 0.02% 230
2023
Q4
$3.67M Buy
503,179
+92,813
+23% +$732K 0.01% 281
2023
Q3
$3.73M Buy
410,366
+192,900
+89% +$2.31M 0.01% 251
2023
Q2
$2.65M Buy
217,466
+120,530
+124% +$1.34M 0.01% 270
2023
Q1
$1.2M Sell
96,936
-5,500
-5% -$101K ﹤0.01% 325
2022
Q4
$1.97M Sell
102,436
-12,000
-10% -$254K 0.01% 267
2022
Q3
$2.15M Sell
114,436
-64,298
-36% -$1.32M 0.01% 207
2022
Q2
$3.22M Buy
+178,734
New +$2.9M 0.01% 121

Other funds holding AHCO

First Eagle Investment Management's AHCO Position: Q3 2025 in Review

First Eagle Investment Management sold out of AdaptHealth (AHCO) in Q3 2025, closing a stake of 729,636 shares — an estimated $6.88M sold.

First Eagle Investment Management first reported a position in AHCO in Q2 2022 and held it in 13 quarters. The position peaked at $10.4M in Q3 2024. 225 funds tracked by Wall St. Rank hold AHCO as of Q3 2025.

  • First Eagle Investment Management reported no remaining AdaptHealth position as of Q3 2025 after selling out during the quarter.
  • First Eagle Investment Management sold 729,636 AdaptHealth shares in Q3 2025, an estimated $6.88M.
  • First Eagle Investment Management first reported a position in AdaptHealth in Q2 2022 and held it in 13 quarters.
  • First Eagle Investment Management's AdaptHealth position peaked at $10.4M in Q3 2024.
  • 225 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2025.

Based on First Eagle Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.